Akt activation through the phosphorylation of erythropoietin receptor at tyrosine 479 is required for myeloproliferative disorder-associated JAK2 V617F mutant-induced cellular transformation
Authors:
- Kenji TagoKTKenji Tago
- Tadashi KasaharaTKTadashi Kasahara
- Megumi Funakoshi-TagoMFMegumi Funakoshi-Tago
- 1 May 2011
- journal article
- Published by Elsevier in Cellular Signalling
- Vol. 23 (5) , 849-856
Abstract
No abstract availableKeywords
Funding Information
- MEXT (19790071)
- Research Foundation for Pharmaceutical Sciences
- Hi-Tech Research Center Project for Private Universities in Japan
This publication has 29 references indexed in Scilit:
- The Constitutive Activation of Jak2-V617F Is Mediated by a π Stacking Mechanism Involving Phenylalanines 595 and 617Biochemistry, 2010
- STAT5 Activation Is Critical for the Transformation Mediated by Myeloproliferative Disorder-associated JAK2 V617F MutantJournal of Biological Chemistry, 2010
- Jak2 FERM Domain Interaction with the Erythropoietin Receptor Regulates Jak2 Kinase ActivityMolecular and Cellular Biology, 2008
- Growth Suppression of Lung Cancer Cells by Targeting Cyclic AMP Response Element-Binding ProteinCancer Research, 2008
- Receptor specific downregulation of cytokine signaling by autophosphorylation in the FERM domain of Jak2The EMBO Journal, 2006
- Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosisCancer Cell, 2005
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005
- Diazoxide-mediated Preconditioning against Apoptosis Involves Activation of cAMP-response Element-binding Protein (CREB) and NFκBJournal of Biological Chemistry, 2004
- NF-κB Antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to Suppress Caspase-8 ActivationScience, 1998
- Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase BNature, 1995